| Jun 26, 2023 |
Jun 28, 2023 |
Avalo Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-3,683,542
|
-82.79%
|
✗
|
$2.2M |
| Feb 3, 2023 |
Feb 9, 2023 |
Avalo Therapeutics, Inc.
|
10% Owner |
Buy |
90.0
|
+450,334
|
11.26%
|
✗
|
$1.3K |
| Mar 10, 2022 |
Mar 14, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
65.0
|
+226,000
|
0.47%
|
✗
|
$151.9K |
| Mar 3, 2022 |
Mar 7, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+510,000
|
1.08%
|
✗
|
$344.1K |
| Feb 24, 2022 |
Feb 28, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
65.0
|
+140,000
|
0.30%
|
✗
|
$111.8K |
| Feb 17, 2022 |
Feb 22, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
72.5
|
+288,000
|
0.62%
|
✗
|
$231.6K |
| Jan 18, 2022 |
Jan 20, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
75.0
|
+312,000
|
0.67%
|
✗
|
$274.5K |
| Jan 12, 2022 |
Jan 14, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
75.0
|
+455,000
|
0.99%
|
✗
|
$452.8K |
| Jan 7, 2022 |
Jan 11, 2022 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+645,000
|
1.42%
|
✗
|
$642.9K |
| Sep 15, 2021 |
Sep 17, 2021 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+5,700,000
|
14.35%
|
✗
|
$12.6M |
| Aug 16, 2021 |
Aug 18, 2021 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+50,000
|
0.13%
|
✗
|
$138.2K |
| Aug 4, 2021 |
Aug 6, 2021 |
Avalo Therapeutics, Inc.
|
10% Owner |
Buy |
67.5
|
+150,000
|
0.38%
|
✗
|
$408.5K |
| Jul 30, 2021 |
Aug 3, 2021 |
KIORA PHARMACEUTICALS INC
|
10% Owner |
Sell |
20.0
|
-260,963
|
-24.95%
|
✗
|
$646.6K |
| Jul 27, 2021 |
Jul 29, 2021 |
KIORA PHARMACEUTICALS INC
|
Director |
Sell |
15.0
|
-3,153,138
|
-75.09%
|
✗
|
$14.5M |
| Jun 16, 2021 |
Jun 22, 2021 |
Vyome Holdings, Inc
|
10% Owner |
Sell |
15.0
|
-2,303,469
|
-22.93%
|
✗
|
$14.2M |
| May 14, 2021 |
May 18, 2021 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
62.5
|
+180,000
|
0.12%
|
✗
|
$392.5K |
| Jan 8, 2021 |
Jan 12, 2021 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
93.8
|
+2,500,000
|
3.98%
|
✗
|
$6.5M |
| Jan 6, 2021 |
Jan 8, 2021 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
100.0
|
+1,531,101
|
29.66%
|
✗
|
$8M |
| Dec 11, 2020 |
Dec 15, 2020 |
AYTU BIOPHARMA, INC
|
Director |
Buy |
100.0
|
+1,333,334
|
100.00%
|
✗
|
$8M |
| Dec 3, 2020 |
Dec 7, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+20,000
|
0.03%
|
✗
|
$48.8K |
| Nov 23, 2020 |
Nov 25, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+100,000
|
0.08%
|
✗
|
$236.9K |
| Sep 4, 2020 |
Sep 9, 2020 |
TENAX THERAPEUTICS, INC.
|
Director |
Buy |
68.8
|
+32,000
|
0.53%
|
✗
|
$45.5K |
| Sep 4, 2020 |
Sep 9, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+100,000
|
0.17%
|
✗
|
$220K |
| Sep 1, 2020 |
Sep 3, 2020 |
TENAX THERAPEUTICS, INC.
|
Director |
Buy |
82.5
|
+86,000
|
1.11%
|
✗
|
$123.2K |
| Aug 27, 2020 |
Aug 31, 2020 |
TENAX THERAPEUTICS, INC.
|
Director |
Buy |
68.8
|
+32,000
|
0.57%
|
✗
|
$47K |
| Aug 24, 2020 |
Aug 26, 2020 |
TENAX THERAPEUTICS, INC.
|
10% Owner |
Buy |
65.0
|
+34,903
|
0.47%
|
✗
|
$52.7K |
| Aug 19, 2020 |
Aug 21, 2020 |
TENAX THERAPEUTICS, INC.
|
Director |
Buy |
90.0
|
+311,481
|
4.67%
|
✗
|
$460.4K |
| Jun 26, 2020 |
Jun 30, 2020 |
Vaxart, Inc.
|
Director |
Sell |
15.0
|
-27,612,053
|
-71.20%
|
✗
|
$267M |
| Jun 9, 2020 |
Jun 11, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
93.8
|
+2,049,486
|
3.42%
|
✗
|
$5.1M |
| Jun 1, 2020 |
Jun 3, 2020 |
Vaxart, Inc.
|
Director |
Sell |
17.5
|
-1,400,000
|
-4.52%
|
✗
|
$3.9M |
| May 27, 2020 |
May 29, 2020 |
Vaxart, Inc.
|
Director |
Sell |
20.0
|
-200,000
|
-1.18%
|
✗
|
$522K |
| May 20, 2020 |
May 22, 2020 |
Vaxart, Inc.
|
Director |
Sell |
16.3
|
-1,750,000
|
-4.74%
|
✗
|
$5.4M |
| May 14, 2020 |
May 18, 2020 |
Vaxart, Inc.
|
Director |
Sell |
16.3
|
-1,943,308
|
-4.31%
|
✗
|
$5.7M |
| May 11, 2020 |
May 13, 2020 |
Vaxart, Inc.
|
Director |
Sell |
16.3
|
-3,406,692
|
-6.17%
|
✗
|
$10M |
| May 6, 2020 |
May 8, 2020 |
Vaxart, Inc.
|
Director |
Sell |
37.5
|
-250,000
|
-0.39%
|
✗
|
$632K |
| May 1, 2020 |
May 5, 2020 |
Vaxart, Inc.
|
Director |
Sell |
16.3
|
-2,650,000
|
-3.85%
|
✗
|
$7.1M |
| Apr 28, 2020 |
Apr 30, 2020 |
Vaxart, Inc.
|
Director |
Sell |
15.0
|
-6,600,000
|
-7.27%
|
✗
|
$20.1M |
| Apr 27, 2020 |
Apr 29, 2020 |
AYTU BIOPHARMA, INC
|
Director |
Sell |
16.3
|
-5,108,921
|
-100.00%
|
✗
|
$9.3M |
| Apr 3, 2020 |
Apr 7, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
47.5
|
+4,280
|
0.01%
|
✗
|
$9.2K |
| Mar 27, 2020 |
Mar 31, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
67.5
|
+111,914
|
0.38%
|
✗
|
$265.3K |
| Mar 20, 2020 |
Mar 24, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+11,000
|
0.04%
|
✗
|
$27.5K |
| Mar 17, 2020 |
Mar 19, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
92.5
|
+1,981,219
|
3.51%
|
✗
|
$4.1M |
| Mar 10, 2020 |
Mar 12, 2020 |
AYTU BIOPHARMA, INC
|
Director |
Sell |
15.0
|
-23,514,440
|
-36.36%
|
✗
|
$33.1M |
| Feb 6, 2020 |
Feb 10, 2020 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
65.0
|
+23,000
|
0.43%
|
✗
|
$140.5K |
| Feb 3, 2020 |
Feb 5, 2020 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
88.8
|
+1,256,282
|
2.14%
|
✗
|
$5M |
| Dec 19, 2019 |
Dec 23, 2019 |
AYTU BIOPHARMA, INC
|
Director |
Buy |
65.0
|
+78,788
|
0.33%
|
✗
|
$67.7K |
| Nov 5, 2019 |
Nov 7, 2019 |
Vaxart, Inc.
|
Director |
Buy |
60.0
|
+200,000
|
0.20%
|
✗
|
$67.3K |
| Oct 4, 2019 |
Oct 7, 2019 |
Vaxart, Inc.
|
10% Owner |
Buy |
72.5
|
+564,000
|
0.76%
|
✗
|
$203.2K |
| Oct 1, 2019 |
Oct 3, 2019 |
Vaxart, Inc.
|
10% Owner |
Buy |
65.0
|
+436,000
|
0.45%
|
✗
|
$150.6K |
| Sep 29, 2019 |
Oct 1, 2019 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
95.0
|
+605,001
|
9.22%
|
✗
|
$1.9M |
| Sep 26, 2019 |
Sep 30, 2019 |
Vaxart, Inc.
|
10% Owner |
Buy |
95.0
|
+7,333,333
|
8.68%
|
✗
|
$2.1M |
| Sep 23, 2019 |
Sep 25, 2019 |
Traws Pharma, Inc.
|
10% Owner |
Sell |
36.3
|
-10,249
|
-0.62%
|
✗
|
$13K |
| Sep 4, 2019 |
Sep 6, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+2,200,000
|
5.62%
|
✗
|
$6.7M |
| Aug 29, 2019 |
Sep 3, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+41,764
|
0.07%
|
✗
|
$134.6K |
| Aug 16, 2019 |
Aug 20, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+12,184
|
0.02%
|
✗
|
$42.2K |
| Aug 12, 2019 |
Aug 14, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
97.5
|
+100,000
|
15.55%
|
✗
|
$332.6K |
| Jun 11, 2019 |
Jun 13, 2019 |
ACHIEVE LIFE SCIENCES, INC.
|
10% Owner |
Sell |
22.5
|
-47,182
|
-1.90%
|
✗
|
$134.8K |
| Jun 11, 2019 |
Jun 13, 2019 |
ACHIEVE LIFE SCIENCES, INC.
|
10% Owner |
Sell |
20.0
|
-252,150
|
-1.59%
|
✗
|
$788.8K |
| Jun 7, 2019 |
Jun 11, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
56.3
|
+10,000
|
0.05%
|
✗
|
$48.8K |
| Jun 3, 2019 |
Jun 5, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+15,000
|
0.03%
|
✗
|
$72.2K |
| May 29, 2019 |
May 31, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+51,000
|
0.07%
|
✗
|
$240.2K |
| May 23, 2019 |
May 28, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+29,000
|
0.04%
|
✗
|
$145.5K |
| May 16, 2019 |
May 20, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+10,000
|
0.02%
|
✗
|
$51.8K |
| May 10, 2019 |
May 14, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+20,000
|
0.03%
|
✗
|
$99.3K |
| Mar 27, 2019 |
Mar 29, 2019 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
72.5
|
+549,647
|
0.79%
|
✗
|
$175.2K |
| Mar 25, 2019 |
Mar 27, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
62.5
|
+50,000
|
0.07%
|
✗
|
$273.3K |
| Mar 6, 2019 |
Mar 8, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
65.0
|
+374,486
|
0.16%
|
✗
|
$2.1M |
| Jan 18, 2019 |
Jan 23, 2019 |
BIO-PATH HOLDINGS, INC.
|
10% Owner |
Sell |
22.5
|
-64,457
|
-19.95%
|
✗
|
$171.6K |
| Jan 9, 2019 |
Jan 11, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+13,996
|
0.08%
|
✗
|
$54.3K |
| Jan 4, 2019 |
Jan 8, 2019 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+27,004
|
0.15%
|
✗
|
$93.9K |
| Dec 28, 2018 |
Dec 31, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+38,799
|
0.04%
|
✗
|
$121.8K |
| Dec 14, 2018 |
Dec 18, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+50,000
|
0.04%
|
✗
|
$165.4K |
| Dec 10, 2018 |
Dec 12, 2018 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
56.3
|
+100,353
|
0.06%
|
✗
|
$40.3K |
| Dec 6, 2018 |
Dec 10, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+36,400
|
0.01%
|
✗
|
$124.1K |
| Nov 30, 2018 |
Dec 4, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+25,797
|
0.02%
|
✗
|
$90.2K |
| Nov 27, 2018 |
Nov 29, 2018 |
Avalo Therapeutics, Inc.
|
10% Owner |
Buy |
62.5
|
+77,803
|
0.06%
|
✗
|
$272.9K |
| Nov 21, 2018 |
Nov 26, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+50,000
|
0.04%
|
✗
|
$179.4K |
| Nov 16, 2018 |
Nov 20, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+49,100
|
0.03%
|
✗
|
$177.3K |
| Nov 14, 2018 |
Nov 16, 2018 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
65.0
|
+360,000
|
0.24%
|
✗
|
$161.4K |
| Nov 13, 2018 |
Nov 15, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+31,314
|
0.02%
|
✗
|
$120.6K |
| Oct 30, 2018 |
Nov 1, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+5,986
|
0.01%
|
✗
|
$23.5K |
| Oct 25, 2018 |
Oct 29, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
62.5
|
+107,800
|
0.07%
|
✗
|
$425.5K |
| Oct 22, 2018 |
Oct 25, 2018 |
Avalo Therapeutics, Inc.
|
10% Owner |
Buy |
55.0
|
+125,800
|
0.04%
|
✗
|
$519.1K |
| Oct 4, 2018 |
Oct 9, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+29,600
|
0.02%
|
✗
|
$128.4K |
| Oct 3, 2018 |
Oct 5, 2018 |
CASSAVA SCIENCES INC
|
10% Owner |
Sell |
20.0
|
-512,660
|
-23.69%
|
✗
|
$671.7K |
| Sep 25, 2018 |
Sep 27, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+20,400
|
0.01%
|
✗
|
$94.6K |
| Aug 16, 2018 |
Aug 20, 2018 |
CASSAVA SCIENCES INC
|
10% Owner |
Sell |
17.5
|
-1,256,000
|
-7.60%
|
✗
|
$1.3M |
| Aug 17, 2018 |
Aug 20, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
92.5
|
+1,000,000
|
2.94%
|
✗
|
$3.9M |
| Jul 30, 2018 |
Aug 1, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,855
|
0.00%
|
✗
|
$12.1K |
| Jul 25, 2018 |
Jul 27, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+28,926
|
0.02%
|
✗
|
$127.6K |
| Jul 16, 2018 |
Jul 18, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+30,019
|
0.02%
|
✗
|
$128.4K |
| Jun 28, 2018 |
Jul 2, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+18,200
|
0.02%
|
✗
|
$74.8K |
| May 25, 2018 |
May 30, 2018 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
48.8
|
+58,275
|
0.05%
|
✗
|
$33.4K |
| May 21, 2018 |
May 23, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
52.5
|
+50,000
|
0.04%
|
✗
|
$189.2K |
| May 18, 2018 |
May 22, 2018 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
47.5
|
+1,725
|
0.01%
|
✗
|
$959.1 |
| May 15, 2018 |
May 17, 2018 |
Avalo Therapeutics, Inc.
|
Director |
Buy |
62.5
|
+130,000
|
0.11%
|
✗
|
$467.6K |
| May 14, 2018 |
May 16, 2018 |
KIORA PHARMACEUTICALS INC
|
Director |
Buy |
47.5
|
+15,758
|
0.02%
|
✗
|
$8.4K |
| May 9, 2018 |
May 11, 2018 |
KIORA PHARMACEUTICALS INC
|
10% Owner |
Buy |
60.0
|
+177,012
|
0.15%
|
✗
|
$91K |
| May 4, 2018 |
May 8, 2018 |
KIORA PHARMACEUTICALS INC
|
10% Owner |
Buy |
60.0
|
+137,230
|
0.06%
|
✗
|
$63.5K |
| Apr 25, 2018 |
Apr 27, 2018 |
KIORA PHARMACEUTICALS INC
|
10% Owner |
Buy |
65.0
|
+165,522
|
0.20%
|
✗
|
$89.3K |